(S1 (S (NP (NP (NP (NN CD14)) (JJ positive) (NNS monocytes)) (PP (IN from) (NP (NP (NN CF) (NNS patients)) (CC and) (NP (NNS controls))))) (VP (VBP show) (NP (NP (JJ similar) (NNS increases)) (PP (IN in) (NP (NN caspase-1) (NN activity)))) (PP (IN upon) (NP (NN inflammasome) (NN stimulation))))))
(S1 (S (S (NP (NNS Monocytes)) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (NN PBMC) (NNS populations))) (S (VP (VBG using) (NP (NN CD14)) (PP (IN as) (NP (DT a) (JJ phenotyping) (NN marker)))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN CD14)) (JJ positive) (NNS monocytes)) (PP (IN from) (NP (NP (NN CF) (NNS patients)) (CC and) (NP (JJ healthy) (NNS controls))))) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NN caspase-1) (NN activation)))) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN LPS+ATP)) (, ,) (NP (NN PAO1)) (, ,) (CC and) (NP (NP (NN LPS+Poly-LRB-dA:dT-RRB-)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4a)) (-RRB- -RRB-))))))))) (CC but) (S (NP (DT this) (NN activation)) (VP (VBD was) (RB not) (ADJP (JJ different) (PP (IN between) (NP (NP (NN CF)) (CC and) (NP (NP (JJ control) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4b)) (-RRB- -RRB-)))))))) (. .)))
